We welcome Aino Råberg as Drug Substance Lead Manufacturing at Scandinavian Biopharma
Scandinavian Biopharma continues to grow and welcome new colleagues. We are now further strengthening our organisation in manufacturing and are pleased to welcome Aino Råberg as our Drug Substance Lead.
Aino has extensive experience from production in the pharmaceutical and life science industry and most recently came from a consulting position where she had various assignments at Octapharma, SOBI and Novavax. Aino led projects in both cultivation and purification, and worked with qualifications, process development and process validations.
– Joining a company that has a vaccine candidate in the late clinical phase feels very exciting. Here I can really use all my previous experiences within this field. To also be able to contribute to a project that can make a real difference feels great. This team is passionate about developing an ETEC vaccine for the whole world, says Aino Råberg.
– Manufacturing of biological drugs is a unique and complex process and having Aino join the team is very important to us. We highly value her previous experience with recombinant proteins, both from commercial production and vaccine production in the development stage, says Björn Sjöstrand, CEO Scandinavian Biopharma.
Aino Råberg, Drug Substance Lead Manufacturing at Scandinavian Biopharma
